FA
ZURA icon

Forefront Analytics’s Zura Bio ZURA Stock Holding History

Forefront Analytics’s Portfolio ZURA Stock Details ZURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$159K Buy
26,968
+12,067
+81% +$57.5K 0.17% 32
2026
Q1 		$88.7K Sell
14,901
-4,676
-24% -$28.2K 0.08% 34
2025
Q4 		$103K Sell
19,577
-1,941
-9% -$7.67K 0.09% 37
2025
Q3 		$93.2K Sell
21,518
-42,467
-66% -$76.4K 0.09% 38
2025
Q2 		$67.2K Sell
63,985
-44,323
-41% -$53K 0.08% 38
2025
Q1 		$140K Buy
108,308
+54,574
+102% +$86.1K 0.16% 37
2024
Q4 		$134K Buy
53,734
+22,924
+74% +$81.7K 0.06% 55
2024
Q3 		$125K Sell
30,810
-10,759
-26% -$40.2K 0.06% 60
2024
Q2 		$145K Buy
41,569
+7,531
+22% +$30.7K 0.07% 58
2024
Q1 		$87.5K Buy
34,038
+12,809
+60% +$45.4K 0.04% 63
2023
Q4 		$99.1K Buy
21,229
+6,765
+47% +$33.8K 0.05% 60
2023
Q3 		$95.5K Buy
+14,464
New +$96.7K 0.05% 54

Other funds holding ZURA

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Forefront Analytics's ZURA Position: Q2 2026 in Review

Forefront Analytics increased its Zura Bio (ZURA) stake by 81% in Q2 2026, buying an estimated $57.5K and bringing the position to 26,968 shares worth $159K. The position accounts for 0.17% of the portfolio, ranked #32.

Forefront Analytics first reported a position in ZURA in Q3 2023 and has held it in 12 quarters since. 95 funds tracked by Wall St. Rank hold ZURA as of Q2 2026.

  • Forefront Analytics held 26,968 shares of Zura Bio worth $159K as of Q2 2026.
  • Forefront Analytics bought 12,067 Zura Bio shares in Q2 2026, an estimated $57.5K.
  • Zura Bio made up 0.17% of Forefront Analytics's portfolio in Q2 2026, its #32 holding.
  • Forefront Analytics first reported a position in Zura Bio in Q3 2023 and has held it in 12 quarters since.
  • 95 funds tracked by Wall St. Rank held Zura Bio as of Q2 2026.

Based on Forefront Analytics's 13F filing for Q2 2026, filed 13 Aug 2026.